US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

RENOVARO BIOSCIENCES INC

0.3089

-0.0039-1.25%

Post-market: 0.3050-0.0039-1.26%19:57 EDT

Volume:2.48M

Turnover:793.19K

Market Cap:53.17M

PE:-0.81

High:0.3350

Open:0.2900

Low:0.2900

Close:0.3128

Loading ...

Overview Company News Filings

BRIEF-Renovaro Completes First Milestone Payment To Finalize Definitive Agreement With Predictive Oncology

BRIEF-Predictive Oncology Moves To Finalize Definitive Merger Agreement With Renovaro Biosciences

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement With Predictive Oncology

THOMSON REUTERS

Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences

THOMSON REUTERS

Predictive Oncology Inc: Expects to Sign a Definitive Merger Agreement Within Next Few Weeks

THOMSON REUTERS

Predictive Oncology Inc - Receives Financing From Renovaro Biosciences

THOMSON REUTERS

Press Release: Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences

Renovaro Agrees to Merge With BioSymetrics

MT Newswires Live

Renovaro Biosciences Buys AI-Driven BioSymetrics

BRIEF-Renovaro & Biosymetrics Announce Definitive Merger Agreement

Renovaro and Biosymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

THOMSON REUTERS

Renovaro: Deal Expected to Close in March 2025

THOMSON REUTERS

Press Release: Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

Renovaro Gets $15 Million in Equity Committed; Shares Rise

MT Newswires Live

Renovaro Announces $15 Million in Equity Committed

THOMSON REUTERS

Renovaro Announces $15 million in Equity Committed

BRIEF-Some Of Renovaro's Financial Statements Contain Material Misstatements, SEC Filing Shows

Renovaro - to Restate Affected Financial Statements

THOMSON REUTERS

Renovaro - Some of Co's Financial Statements Should No Longer Be Relied Upon

THOMSON REUTERS

Renovaro Names Nathen Fuentes as CFO

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RENB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RENB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RENB\",,,,,undefined,":{"symbol":"RENB","market":"US","secType":"STK","nameCN":"RENOVARO BIOSCIENCES INC","latestPrice":0.3089,"timestamp":1749240000000,"preClose":0.3128,"halted":0,"volume":2484215,"hourTrading":{"tag":"盘后","latestPrice":0.305,"preClose":0.3089,"latestTime":"19:57 EDT","volume":13445,"amount":4146.5314,"timestamp":1749254274090},"delay":0,"floatShares":90925900,"shares":172118569,"eps":-0.379223,"marketStatus":"Market Closed","change":-0.0039,"latestTime":"06-06 16:00:00 EDT","open":0.29,"high":0.335,"low":0.29,"amount":793190.29872795,"amplitude":0.143862,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.379223,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.3128,"preHourTrading":{"tag":"盘前","latestPrice":0.2953,"preClose":0.3128,"latestTime":"09:29 EDT","volume":23379,"amount":6800.115534539999,"timestamp":1749216599080},"postHourTrading":{"tag":"盘后","latestPrice":0.305,"preClose":0.3089,"latestTime":"19:57 EDT","volume":13445,"amount":4146.5314,"timestamp":1749254274090},"volumeRatio":0.142387197482589,"impliedVol":0.3452,"impliedVolPercentile":0.216},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RENB\",,,,,undefined,":{"symbol":"RENB","floatShares":90925900,"roa":"-8.41%","roe":"-53.17%","lyrEps":-0.83794,"volumeRatio":0.142387197482589,"shares":172118569,"dividePrice":0,"high":0.335,"amplitude":0.143862,"preClose":0.3128,"low":0.29,"week52Low":0.27,"pbRate":"0.60","week52High":2.34,"institutionHeld":0,"latestPrice":0.3089,"eps":-0.379223,"divideRate":0,"volume":2484215,"delay":0,"ttmEps":-0.379223,"open":0.29,"prevYearClose":0.8355,"prevWeekClose":0.3097,"prevMonthClose":0.3097,"prevQuarterClose":0.5432,"fiveDayClose":0.3097,"twentyDayClose":0.308,"sixtyDayClose":0.8619},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RENB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516634249","title":"BRIEF-Renovaro Completes First Milestone Payment To Finalize Definitive Agreement With Predictive Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634249","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516634249?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:47","pubTimestamp":1741013249,"startTime":"0","endTime":"0","summary":"BRIEF-Renovaro Completes First Milestone Payment To Finalize Definitive Agreement With Predictive OncologyMarch 3 (Reuters) - Predictive Oncology Inc POAI.O:RENOVARO COMPLETES FIRST MILESTONE PAYMENT ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA8DTSBL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","RENB","BK4139","BK4198","POAI"],"gpt_icon":0},{"id":"2516631941","title":"BRIEF-Predictive Oncology Moves To Finalize Definitive Merger Agreement With Renovaro Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2516631941","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516631941?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:24","pubTimestamp":1741011852,"startTime":"0","endTime":"0","summary":"BRIEF-Predictive Oncology Moves To Finalize Definitive Merger Agreement With Renovaro BiosciencesMarch 3 (Reuters) - Predictive Oncology Inc POAI.O:PREDICTIVE ONCOLOGY MOVES TO FINALIZE DEFINITIVE MER","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA7NYBDG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RENB","BK4139","POAI","BK4198","BK4082"],"gpt_icon":0},{"id":"2516063133","title":"Renovaro Completes First Milestone Payment to Finalize Definitive Agreement With Predictive Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2516063133","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516063133?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:15","pubTimestamp":1741011300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA8DTSBL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["POAI","BK4139","BK4082","RENB","BK4198"],"gpt_icon":0},{"id":"2516639584","title":"Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2516639584","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516639584?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:00","pubTimestamp":1741010403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA7NYBDG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","BK4082","POAI","BK4139","RENB"],"gpt_icon":0},{"id":"2516257639","title":"Predictive Oncology Inc: Expects to Sign a Definitive Merger Agreement Within Next Few Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2516257639","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516257639?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:00","pubTimestamp":1741010403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA7NYBDG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","POAI","BK4198","BK4139","RENB"],"gpt_icon":0},{"id":"2516063925","title":"Predictive Oncology Inc - Receives Financing From Renovaro Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2516063925","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516063925?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:00","pubTimestamp":1741010403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA7NYBDG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["POAI","BK4198","BK4139","BK4082","RENB"],"gpt_icon":0},{"id":"2516399416","title":"Press Release: Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2516399416","media":"Dow Jones","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516399416?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:00","pubTimestamp":1741010400,"startTime":"0","endTime":"0","summary":"Predictive receives first tranche of financing to initiate integration. of AI/ML platform technologies, core laboratory capabilities and business development efforts in Europe and the United States. Renovaro's recent strategic acquisition of BioSymetrics vastly expands Predictive Oncology's biomarker and drug discovery opportunities and the development of diagnostic applications in oncology. Merger expected to enhance shareholder value, accelerate business development efforts and solidify positioning in the capital markets. Predictive and Renovaro reiterate their unwavering commitment to improving the outcomes of cancer patients through earlier diagnosis, biomarker discovery and targeted therapies by integrating and leveraging Predictive's AI-driven drug discovery platform, vast biobank of more than 150,000 patient tumor samples, 200,000 pathology slides and decades of longitudinal drug response data with Renovaro's multi-disciplinary artificial intelligence, multi-omic and multi-modal","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4198","POAI","BK4139","RENB"],"gpt_icon":0},{"id":"2514986964","title":"Renovaro Agrees to Merge With BioSymetrics","url":"https://stock-news.laohu8.com/highlight/detail?id=2514986964","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514986964?lang=en_us&edition=fundamental","pubTime":"2025-02-27 02:46","pubTimestamp":1740595584,"startTime":"0","endTime":"0","summary":"Renovaro (RENB) said Wednesday it agreed to a merger with artificial intelligence-driven drug discovery company BioSymetrics.Financial terms of the transaction were not disclosed.The company said it e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2514520869","title":"Renovaro Biosciences Buys AI-Driven BioSymetrics","url":"https://stock-news.laohu8.com/highlight/detail?id=2514520869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514520869?lang=en_us&edition=fundamental","pubTime":"2025-02-27 02:44","pubTimestamp":1740595440,"startTime":"0","endTime":"0","summary":"Renovaro Biosciences said Wednesday that it is buying BioSymetrics, an artificial intelligence-driven drug discovery and biomarker identification company.Renovaro said the transaction will improve its data repository, biomarker discovery capabilities and accelerate translational research.BioSymetrics' proprietary platform is called Elion, an AI and machine learning engine that uncovers complex biological relationships to speed up the discovery of diagnostics and therapeutics. Its Phenograph platform provides a translational engine that maps human clinical signals to prioritized therapeutic targets.Renovaro said that through this merger, it will gain access to cutting-edge computational tools that enhance the ability to stratify patients, predict treatment responses, and drive more effective therapeutic interventions.The transaction is expected to close in March, subject to customary closing conditions and regulatory approvals.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2514086614","title":"BRIEF-Renovaro & Biosymetrics Announce Definitive Merger Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2514086614","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514086614?lang=en_us&edition=fundamental","pubTime":"2025-02-27 02:27","pubTimestamp":1740594460,"startTime":"0","endTime":"0","summary":"BRIEF-Renovaro & Biosymetrics Announce Definitive Merger AgreementFeb 26 (Reuters) - Renovaro Inc RENB.O:RENOVARO AND BIOSYMETRICS ANNOUNCE DEFINITIVE MERGER AGREEMENT TO ADVANCE AI-DRIVEN BIOMARKER D","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH0ZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2514925866","title":"Renovaro and Biosymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2514925866","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514925866?lang=en_us&edition=fundamental","pubTime":"2025-02-27 02:25","pubTimestamp":1740594306,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH0ZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2514661218","title":"Renovaro: Deal Expected to Close in March 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514661218","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514661218?lang=en_us&edition=fundamental","pubTime":"2025-02-27 02:25","pubTimestamp":1740594306,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH0ZY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2514866124","title":"Press Release: Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2514866124","media":"Dow Jones","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514866124?lang=en_us&edition=fundamental","pubTime":"2025-02-27 02:25","pubTimestamp":1740594300,"startTime":"0","endTime":"0","summary":"Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine. Strategic Combination Aims to Accelerate Biomarker Identification, Enhance Drug Discovery, and Expand Precision Medicine Applications in Cancer and Beyond. LOS ANGELES, Feb. 26, 2025  -- Renovaro Biosciences Inc. , a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today announced a definitive agreement to merge with BioSymetrics, an artificial intelligence -driven drug discovery and biomarker identification company. This transformative partnership is designed to enhance Renovaro's data repository, biomarker discovery capabilities, accelerate translational research, and bring precision medicine solutions to cancer and other critical disease areas.\"This merger represents a pivotal step in our mission to diagnose cancer and advance precision medicine,\" said David Weinstein, CEO of Renovaro. \"By com","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2514170852","title":"Renovaro Gets $15 Million in Equity Committed; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2514170852","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514170852?lang=en_us&edition=fundamental","pubTime":"2025-02-26 23:57","pubTimestamp":1740585475,"startTime":"0","endTime":"0","summary":"Renovaro  said Wednesday it has $15 million in additional equity committed at $1 per share.The company also said it has one privately placed cash warrant exercisable at $1.50 with a one year term.The shares were up more than 17% in recent trading.Price: 0.91, Change: +0.14, Percent Change: +17.72","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","EQR","BK4585","BK4215","RENB","BK4139"],"gpt_icon":0},{"id":"2514853471","title":"Renovaro Announces $15 Million in Equity Committed","url":"https://stock-news.laohu8.com/highlight/detail?id=2514853471","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514853471?lang=en_us&edition=fundamental","pubTime":"2025-02-26 22:15","pubTimestamp":1740579309,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH0U3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2514685374","title":"Renovaro Announces $15 million in Equity Committed","url":"https://stock-news.laohu8.com/highlight/detail?id=2514685374","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514685374?lang=en_us&edition=fundamental","pubTime":"2025-02-26 22:15","pubTimestamp":1740579300,"startTime":"0","endTime":"0","summary":"LOS ANGELES, Feb.  26, 2025  (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announces that it has $15 mill","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/26/3033011/0/en/Renovaro-Announces-15-million-in-Equity-Committed.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","EQR","BK4215","RENB","BK4588"],"gpt_icon":0},{"id":"2512748672","title":"BRIEF-Some Of Renovaro's Financial Statements Contain Material Misstatements, SEC Filing Shows","url":"https://stock-news.laohu8.com/highlight/detail?id=2512748672","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512748672?lang=en_us&edition=fundamental","pubTime":"2025-02-19 23:36","pubTimestamp":1739979373,"startTime":"0","endTime":"0","summary":"BRIEF-Some Of Renovaro's Financial Statements Contain Material Misstatements, SEC Filing ShowsFeb 19 (Reuters) - Renovaro Inc RENB.O:RENOVARO - SOME OF CO'S  FINANCIAL STATEMENTS SHOULD NO LONGER BE R","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nFWN3PA0M7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2512399107","title":"Renovaro - to Restate Affected  Financial Statements","url":"https://stock-news.laohu8.com/highlight/detail?id=2512399107","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512399107?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:49","pubTimestamp":1739972996,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nFWN3PA0M7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2512073131","title":"Renovaro - Some of Co's  Financial Statements Should No Longer Be Relied Upon","url":"https://stock-news.laohu8.com/highlight/detail?id=2512073131","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512073131?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:49","pubTimestamp":1739972996,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nFWN3PA0M7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2501783819","title":"Renovaro Names Nathen Fuentes as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2501783819","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501783819?lang=en_us&edition=fundamental","pubTime":"2025-01-07 23:02","pubTimestamp":1736262170,"startTime":"0","endTime":"0","summary":"Renovaro  said Tuesday it has appointed Nathen Fuentes as chief financial officer, replacing interim CFO Simon Tarsh.Fuentes, whose appointment took effect Jan. 2, was previously CFO at Telomir Pharmaceuticals , Renovaro said.Renovaro shares rose 3% in recent Tuesday trading.Price: 1.03, Change: +0.03, Percent Change: +3.30","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RENB","BK4139","TELO","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":71,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RENB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"RENB","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":0},{"market":"US","date":"2025-02-19","symbol":"RENB","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739941200000,"reportTimeType":"post","actualEps":-0.02},{"market":"US","date":"2024-11-14","symbol":"RENB","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2024-10-10","symbol":"RENB","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1728532800000,"reportTimeType":"post","actualEps":-0.45},{"market":"US","date":"2024-05-15","symbol":"RENB","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RENB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RENB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RENB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RENB","date":"2025-06-06","current":-0.908958,"percent":0.822989,"low":-11.254936,"twenty":-5.896087,"median":-1.835309,"eighty":-0.938951,"high":-0.425746,"avg":-3.373134,"sd":2.934595,"marketCap":53838688},"quantilePoints":[{"date":"2023-08-11","current":-0.842296,"twenty":-0.858231,"median":-0.663023,"eighty":-0.461441,"marketCap":89892200},{"date":"2023-08-18","current":-0.921973,"twenty":-0.901484,"median":-0.882134,"eighty":-0.681804,"marketCap":98395516},{"date":"2023-08-25","current":-1.38865,"twenty":-1.080188,"median":-0.904899,"eighty":-0.830914,"marketCap":148200654},{"date":"2023-09-01","current":-1.781342,"twenty":-1.390926,"median":-1.024414,"eighty":-0.866199,"marketCap":190109855},{"date":"2023-09-08","current":-1.838254,"twenty":-1.738089,"median":-1.138238,"eighty":-0.882134,"marketCap":196183652},{"date":"2023-09-15","current":-1.804107,"twenty":-1.831424,"median":-1.371576,"eighty":-0.88441,"marketCap":192539374},{"date":"2023-09-22","current":-2.191108,"twenty":-1.848498,"median":-1.479709,"eighty":-0.901484,"marketCap":233841196},{"date":"2023-09-29","current":-2.316314,"twenty":-1.946387,"median":-1.676055,"eighty":-0.933355,"marketCap":247203550},{"date":"2023-10-06","current":-7.118779,"twenty":-2.179726,"median":-1.781342,"eighty":-0.980023,"marketCap":282502019},{"date":"2023-10-13","current":-7.74788,"twenty":-5.197793,"median":-1.82118,"eighty":-1.031244,"marketCap":307467313},{"date":"2023-10-20","current":-5.711578,"twenty":-7.168445,"median":-1.855328,"eighty":-1.080188,"marketCap":226658596},{"date":"2023-10-27","current":-4.635484,"twenty":-7.135334,"median":-1.855328,"eighty":-1.118888,"marketCap":183954803},{"date":"2023-11-03","current":-5.049366,"twenty":-7.026069,"median":-1.943541,"eighty":-1.206532,"marketCap":200379339},{"date":"2023-11-10","current":-4.689234,"twenty":-6.615498,"median":-2.10574,"eighty":-1.302144,"marketCap":186087821},{"date":"2023-11-17","current":-4.561671,"twenty":-5.969841,"median":-2.191108,"eighty":-1.374991,"marketCap":187755275},{"date":"2023-11-24","current":-5.396221,"twenty":-5.585435,"median":-2.219564,"eighty":-1.390926,"marketCap":222104819},{"date":"2023-12-01","current":-5.396221,"twenty":-5.49345,"median":-4.524078,"eighty":-1.428488,"marketCap":222104819},{"date":"2023-12-08","current":-5.444836,"twenty":-5.444836,"median":-4.635484,"eighty":-1.545727,"marketCap":224105763},{"date":"2023-12-15","current":-5.720319,"twenty":-5.636053,"median":-4.686221,"eighty":-1.656136,"marketCap":235444448},{"date":"2023-12-22","current":-5.412426,"twenty":-5.636053,"median":-4.701705,"eighty":-1.675486,"marketCap":222771800},{"date":"2023-12-29","current":-5.169353,"twenty":-5.606885,"median":-4.76643,"eighty":-1.678901,"marketCap":212767079},{"date":"2024-01-05","current":-5.847089,"twenty":-5.626331,"median":-4.823692,"eighty":-1.699389,"marketCap":240662238},{"date":"2024-01-12","current":-7.088371,"twenty":-5.780749,"median":-4.953966,"eighty":-1.754024,"marketCap":291752546},{"date":"2024-01-19","current":-7.349693,"twenty":-6.206408,"median":-5.070988,"eighty":-1.790448,"marketCap":302508400},{"date":"2024-01-26","current":-7.962168,"twenty":-7.106616,"median":-5.169353,"eighty":-1.810936,"marketCap":327717433},{"date":"2024-02-02","current":-7.072038,"twenty":-7.137369,"median":-5.263632,"eighty":-1.82118,"marketCap":291080305},{"date":"2024-02-09","current":-5.896087,"twenty":-7.137369,"median":-5.347607,"eighty":-1.82801,"marketCap":242678961},{"date":"2024-02-16","current":-6.969,"twenty":-7.137369,"median":-5.363812,"eighty":-1.845084,"marketCap":287336744},{"date":"2024-02-23","current":-6.969,"twenty":-7.150435,"median":-5.387578,"eighty":-1.855328,"marketCap":287336744},{"date":"2024-03-01","current":-8.990011,"twenty":-7.198517,"median":-5.396221,"eighty":-1.861019,"marketCap":370664399},{"date":"2024-03-08","current":-10.418656,"twenty":-7.379651,"median":-5.404324,"eighty":-1.89289,"marketCap":429568432},{"date":"2024-03-15","current":-10.906486,"twenty":-7.477571,"median":-5.444836,"eighty":-1.935004,"marketCap":449682004},{"date":"2024-03-22","current":-10.244431,"twenty":-7.594683,"median":-5.466304,"eighty":-1.975981,"marketCap":422385013},{"date":"2024-03-28","current":-9.721756,"twenty":-7.6659,"median":-5.49345,"eighty":-2.048828,"marketCap":400834757},{"date":"2024-04-05","current":-9.721756,"twenty":-7.780991,"median":-5.585767,"eighty":-2.162652,"marketCap":400834757},{"date":"2024-04-12","current":-8.537025,"twenty":-7.909815,"median":-5.683539,"eighty":-2.162652,"marketCap":351987511},{"date":"2024-04-19","current":-8.01435,"twenty":-8.049195,"median":-5.736523,"eighty":-2.191108,"marketCap":330437255},{"date":"2024-04-26","current":-5.92365,"twenty":-8.01435,"median":-5.889227,"eighty":-2.196799,"marketCap":244236232},{"date":"2024-05-03","current":-5.191905,"twenty":-7.962168,"median":-5.736523,"eighty":-2.219564,"marketCap":214065874},{"date":"2024-05-10","current":-4.1814,"twenty":-7.909815,"median":-5.683539,"eighty":-2.316314,"marketCap":172402046},{"date":"2024-05-17","current":-2.443812,"twenty":-7.872338,"median":-5.585767,"eighty":-2.443812,"marketCap":131786997},{"date":"2024-05-24","current":-3.61057,"twenty":-7.790675,"median":-5.49948,"eighty":-2.523736,"marketCap":194706526},{"date":"2024-05-31","current":-4.020862,"twenty":-7.782928,"median":-5.490611,"eighty":-2.561678,"marketCap":216832267},{"date":"2024-06-07","current":-3.637923,"twenty":-7.780991,"median":-5.444836,"eighty":-2.581602,"marketCap":196181575},{"date":"2024-06-14","current":-3.966156,"twenty":-7.761124,"median":-5.43582,"eighty":-2.609206,"marketCap":213882168},{"date":"2024-06-21","current":-3.938803,"twenty":-7.742964,"median":-5.412426,"eighty":-2.63681,"marketCap":212407119},{"date":"2024-06-28","current":-4.10292,"twenty":-7.738048,"median":-5.396221,"eighty":-2.647751,"marketCap":221257416},{"date":"2024-07-05","current":-4.321743,"twenty":-7.714683,"median":-5.396221,"eighty":-2.94281,"marketCap":233057811},{"date":"2024-07-12","current":-3.966156,"twenty":-7.699226,"median":-5.387578,"eighty":-3.371454,"marketCap":213882168},{"date":"2024-07-15","current":-3.966156,"twenty":-7.69872,"median":-5.380016,"eighty":-3.449983,"marketCap":213882168},{"date":"2024-08-02","current":-1.91497,"twenty":-7.698214,"median":-5.371914,"eighty":-3.135869,"marketCap":103268211},{"date":"2024-08-09","current":-1.773009,"twenty":-7.6659,"median":-5.347607,"eighty":-2.571163,"marketCap":95612704},{"date":"2024-08-16","current":-1.858076,"twenty":-7.631055,"median":-5.298934,"eighty":-2.219564,"marketCap":100200108},{"date":"2024-08-23","current":-1.800361,"twenty":-7.615438,"median":-5.234173,"eighty":-2.162652,"marketCap":97087754},{"date":"2024-08-30","current":-1.096953,"twenty":-7.594683,"median":-5.191905,"eighty":-1.942322,"marketCap":96659989},{"date":"2024-09-06","current":-0.956172,"twenty":-7.594683,"median":-5.169353,"eighty":-1.883292,"marketCap":84254824},{"date":"2024-09-13","current":-1.039201,"twenty":-7.568029,"median":-5.122215,"eighty":-1.855328,"marketCap":91571069},{"date":"2024-09-20","current":-0.898922,"twenty":-7.561365,"median":-5.068368,"eighty":-1.82118,"marketCap":79210154},{"date":"2024-09-27","current":-0.801832,"twenty":-7.538402,"median":-4.941343,"eighty":-1.780605,"marketCap":70654868},{"date":"2024-10-04","current":-0.840501,"twenty":-7.499872,"median":-4.812365,"eighty":-1.72119,"marketCap":74062232},{"date":"2024-10-11","current":-0.852916,"twenty":-7.482618,"median":-4.731822,"eighty":-1.672382,"marketCap":68787798},{"date":"2024-10-18","current":-1.441668,"twenty":-7.469223,"median":-4.689234,"eighty":-1.611745,"marketCap":116270748},{"date":"2024-10-25","current":-0.987903,"twenty":-7.425307,"median":-4.683207,"eighty":-1.393203,"marketCap":79674514},{"date":"2024-10-31","current":-1.045809,"twenty":-7.406141,"median":-4.602373,"eighty":-1.33948,"marketCap":84344712},{"date":"2024-11-08","current":-1.091709,"twenty":-7.392372,"median":-4.486173,"eighty":-1.206786,"marketCap":88046508},{"date":"2024-11-15","current":-0.800809,"twenty":-7.364672,"median":-4.349095,"eighty":-1.204333,"marketCap":92643312},{"date":"2024-11-22","current":-0.687074,"twenty":-7.320294,"median":-4.29439,"eighty":-1.148518,"marketCap":79485644},{"date":"2024-11-29","current":-1.037745,"twenty":-7.274563,"median":-4.196865,"eighty":-1.139226,"marketCap":120053797},{"date":"2024-12-06","current":-1.975612,"twenty":-7.221841,"median":-4.130273,"eighty":-1.130296,"marketCap":228552972},{"date":"2024-12-13","current":-2.359759,"twenty":-7.19548,"median":-4.075567,"eighty":-1.139226,"marketCap":272993828},{"date":"2024-12-20","current":-2.119667,"twenty":-7.179834,"median":-4.020862,"eighty":-1.141284,"marketCap":245218293},{"date":"2024-12-27","current":-1.243675,"twenty":-7.166767,"median":-4.020862,"eighty":-1.14292,"marketCap":143877270},{"date":"2025-01-03","current":-1.046937,"twenty":-7.153701,"median":-3.966156,"eighty":-1.14215,"marketCap":121117203},{"date":"2025-01-10","current":-1.144209,"twenty":-7.140635,"median":-3.966156,"eighty":-1.143797,"marketCap":132370263},{"date":"2025-01-17","current":-1.028965,"twenty":-7.137369,"median":-3.938144,"eighty":-1.135591,"marketCap":119038006},{"date":"2025-01-24","current":-1.426831,"twenty":-7.127569,"median":-3.911451,"eighty":-1.121942,"marketCap":165066035},{"date":"2025-01-31","current":-1.049818,"twenty":-7.119682,"median":-3.884098,"eighty":-1.119209,"marketCap":121450510},{"date":"2025-02-07","current":-0.921952,"twenty":-7.100534,"median":-3.630902,"eighty":-1.092825,"marketCap":106658053},{"date":"2025-02-14","current":-1.017989,"twenty":-7.088371,"median":-3.528511,"eighty":-1.069204,"marketCap":117768267},{"date":"2025-02-21","current":-1.135052,"twenty":-7.081838,"median":-2.653222,"eighty":-1.076928,"marketCap":134401986},{"date":"2025-02-28","current":-1.347103,"twenty":-7.065505,"median":-2.598891,"eighty":-1.076928,"marketCap":159511096},{"date":"2025-03-07","current":-1.131299,"twenty":-7.048899,"median":-2.565552,"eighty":-1.088965,"marketCap":133957577},{"date":"2025-03-14","current":-1.060525,"twenty":-7.03869,"median":-2.436084,"eighty":-1.088965,"marketCap":125577293},{"date":"2025-03-21","current":-0.927155,"twenty":-7.03869,"median":-2.359759,"eighty":-1.067398,"marketCap":109784900},{"date":"2025-03-28","current":-0.870591,"twenty":-7.024371,"median":-2.291162,"eighty":-1.047047,"marketCap":103087022},{"date":"2025-04-04","current":-0.635556,"twenty":-6.989335,"median":-2.250002,"eighty":-1.040362,"marketCap":75256474},{"date":"2025-04-11","current":-0.49022,"twenty":-6.969,"median":-2.193954,"eighty":-1.037745,"marketCap":58047218},{"date":"2025-04-17","current":-0.486705,"twenty":-6.948093,"median":-2.165169,"eighty":-1.032556,"marketCap":57630994},{"date":"2025-04-25","current":-0.50401,"twenty":-6.778585,"median":-2.119667,"eighty":-1.025324,"marketCap":59680096},{"date":"2025-05-02","current":-0.454061,"twenty":-6.419499,"median":-1.993022,"eighty":-1.012661,"marketCap":53765569},{"date":"2025-05-09","current":-0.45186,"twenty":-6.353202,"median":-1.942322,"eighty":-0.992001,"marketCap":53504992},{"date":"2025-05-16","current":-0.966785,"twenty":-6.271738,"median":-1.899377,"eighty":-0.986031,"marketCap":57263847},{"date":"2025-05-23","current":-0.968819,"twenty":-5.993063,"median":-1.858076,"eighty":-0.967192,"marketCap":57384330},{"date":"2025-05-30","current":-0.915351,"twenty":-5.92365,"median":-1.855328,"eighty":-0.961053,"marketCap":54217349},{"date":"2025-06-06","current":-0.908958,"twenty":-5.896087,"median":-1.835309,"eighty":-0.938951,"marketCap":53838688}],"updateTime":1749419175194}}}